General healthcare/wound care issues Pandemic and All Hazards Preparedness Act Reauthorization Appropriations Issues
2026 · 2nd Quarter (Apr 1 - June 30)
RECCE PHARMACEUTICALS LTD
Filed by RK STRATEGIES, INC..
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 18, 2026
- Income
- $20,000.00
- Expenses
- Not reported
- Registrant
- RK STRATEGIES, INC.
- Filing UUID
- 121905d9-f212-4447-a3cf-eafce2d4123c
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
General biodefense/wound care issues Pandemic and All Hazards Preparedness Act Reauthorization Other Appropriations Issues Related to Wound Care/Biodefense
General wound care issues
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.